An; Eunkyung

Patent Applications and Registrations

Patent applications and USPTO patent grants for An; Eunkyung.The latest application filed is for "srm/mrm assay for the cyclin-dependent kinase inhibitor 2a (p16) protein".

Company Profile

3.7.11

An; Eunkyung - Bethesda MD
An; Eunkyung - Besthesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein Grant 10,620,184 - Krizman , et al.	2020-04-14
SRM/MRM Assay for the Cyclin-Dependent Kinase Inhibitor 2A (p16) protein App 20190178866 - KRIZMAN; David B. ; et al.	2019-06-13
SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein App 20190056406 - KRIZMAN; David B. ; et al.	2019-02-21
Quantifying Her2 protein for optimal cancer therapy Grant 10,208,130 - Bang , et al. Feb	2019-02-19
SRM/MRM assay for the androgen receptor (AR) protein Grant 10,126,307 - Krizman , et al. November 13, 2	2018-11-13
SRM/MRM assay for the mesothelin (MSLN) protein Grant 10,078,084 - Krizman , et al. September 18, 2	2018-09-18
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein Grant 10,073,075 - Krizman , et al. September 11, 2	2018-09-11
SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein Grant 10,060,927 - Krizman , et al. August 28, 2	2018-08-28
Quantifying FR-.alpha. and GART proteins for optimal cancer therapy Grant 9,746,477 - Hembrough , et al. August 29, 2	2017-08-29
Srm Assays To Chemotherapy Targets App 20170168057 - KRIZMAN; David B. ; et al.	2017-06-15
SRM/MRM Assays App 20170168055 - Krizman; David ; et al.	2017-06-15
SRM/MRM Assay for the Androgen Receptor (AR) Protein App 20170052197 - KRIZMAN; David B. ; et al.	2017-02-23
Quantifying FR-alpha and GART Proteins for Optimal Cancer Therapy App 20170030923 - HEMBROUGH; Todd ; et al.	2017-02-02
Quantifying Her2 Protein for Optimal Cancer Therapy App 20160349259 - BANG; Yung-Jue ; et al.	2016-12-01
SRM/MRM Assay for the Cyclin-Dependent Kinase Inhibitor 2A (p16) protein App 20160341713 - KRIZMAN; David B. ; et al.	2016-11-24
SRM/MRM Assay for the Mesothelin (MSLN) protein App 20160334411 - KRIZMAN; David B. ; et al.	2016-11-17
SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein App 20160334408 - KRIZMAN; David B. ; et al.	2016-11-17
SRM Assay for PD-L1 App 20160313343 - KRIZMAN; David B. ; et al.	2016-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.